
  
    
      
        Background_NNP
        
        Bacillus_NN thuringiensis_NNS (_( Bt_NNP )_) has_VBZ been_VBN
        sold_VBN commericially_RB and_CC used_VBN as_IN a_DT biopesticide_NN worldwide_NN for_IN
        over_IN half_PDT a_DT century_NN ._. However_RB ,_, growing_VBG public_JJ concern_NN
        surrounding_VBG Bt_NNP use_NN has_VBZ sparked_VBN worldwide_NN debate_NN over_IN
        current_JJ policies_NNS [_NN 1_CD ]_NN ._. For_IN example_NN ,_, in_IN India_NNP ,_, fear_NN over_IN a_DT
        potential_JJ 
        Bombyx_NNP mori_NN (_( silkworm_NN )_) epizootic_JJ ,_, or_CC
        microbial_NN pathogen_NN outbreak_NN ,_, inspired_VBD a_DT governmental_JJ ban_NN on_IN
        the_DT use_NN of_IN Bt_NNP ,_, despite_IN the_DT nation_NN 's_POS continuing_VBG use_NN of_IN
        traditional_JJ chemical_NN pesticides_NNS [_NN 2_CD ]_NN ._.
        While_IN pest_NN control_NN with_IN Cry_NNP toxins_NNS that_WDT possess_VBP low_JJ 
        B_NNP ._. mori_NN activity_NN (_( 
        i_NNP ._. e_SYM ._. Cry_NNP 1_CD Ac_NNP )_) is_VBZ a_DT viable_JJ solution_NN in_IN
        affected_VBN countries_NNS ,_, it_PRP is_VBZ worthwhile_JJ to_TO investigate_VB the_DT
        specific_JJ molecular_JJ mechanisms_NNS that_WDT make_VBP Cry_NNP 1_CD Aa_NNP highly_RB
        active_JJ ._. Early_RB work_NN took_VBD advantage_NN of_IN the_DT fact_NN that_IN Cry_NNP 1_CD Aa_NNP ,_,
        but_CC not_RB Cry_NNP 1_CD Ac_NNP ,_, is_VBZ toxic_JJ to_TO 
        B_NNP ._. mori_NN ._. For_IN example_NN ,_, Ge_NNP 
        et_CC al_NN ._. [_NN 3_CD ]_NN exchanged_VBD hypervariable_JJ
        regions_NNS between_IN genes_NNS encoding_VBG the_DT two_CD toxins_NNS and_CC localized_JJ
        the_DT toxicity_NN specifying_VBG region_NN of_IN Cry_NNP 1_CD Aa_NNP to_TO residues_NNS
        332_CD -_: 450_CD in_IN domain_NN II_NNP ._. A_DT follow-up_JJ study_NN demonstrated_VBD the_DT
        toxicity_NN specifying_VBG residues_NNS were_VBD involved_VBN in_IN binding_JJ 
        B_NNP ._. mori_NN brush_NN border_NN membrane_NN
        vesicles_NNS [_NN 4_CD ]_NN ._. More_RBR specifically_RB ,_, alanine_NN substitution_NN or_CC
        deletion_NN of_IN residues_NNS 365_CD to_TO 371_CD removed_VBN nearly_RB all_DT toxicity_NN
        and_CC binding_JJ to_TO 
        B_NNP ._. mori_NN BBMV_NNP [_NN 5_CD ]_NN ._.
        Recently_RB ,_, research_NN on_IN 
        B_NNP ._. mori_NN has_VBZ focused_VBN on_IN purifying_VBG and_CC
        cloning_VBG the_DT midgut_NN epithelial_NN receptors_NNS targeted_VBN by_IN Cry_NNP 1_CD Aa_NNP
        toxin_NN ._. The_DT first_JJ toxin-binding_JJ receptor_NN purified_JJ from_IN 
        B_NNP ._. mori_NN was_VBD a_DT 120_CD -_: kDa_NN aminopeptidase_NN
        N_NNP (_( APN_NNP )_) ,_, which_WDT appears_VBZ around_IN 110_CD -_: kDa_NN on_IN SDS-PAGE_NNP gels_NNS when_WRB
        preparative_JJ conditions_NNS are_VBP used_VBN that_DT cleave_NN its_PRP$
        glycosyl-phosphatidylinositol_JJ (_( GPI_NNP )_) anchor_VB ._. This_DT receptor_NN
        was_VBD shown_VBN to_TO bind_NN Cry_NNP 1_CD Aa_NNP with_IN a_DT 7_CD ._. 6_CD nM_NN affinity_NN ,_, as_IN
        determined_VBN by_IN Scatchard_NNP analysis_NN with_IN ELISA_NNP binding_JJ assays_NNS
        [_NN 6_CD ]_NN ._. The_DT APN_NNP was_VBD cloned_VBN and_CC expressed_VBN in_IN 
        E_NNP ._. coli_NNS and_CC demonstrated_VBN to_TO bind_NN
        Cry_NNP 1_CD Aa_NNP toxin_NN on_IN ligand_NN blots_NNS [_NN 7_CD ]_NN ._. These_DT results_NNS indicate_VBP
        the_DT Cry_NNP 1_CD Aa-_NNP APN_NNP interaction_NN was_VBD specific_JJ and_CC that_IN APN_NNP
        glycosylation_NN was_VBD not_RB required_VBN for_IN Cry_NNP 1_CD Aa_NNP binding_JJ ._. This_DT is_VBZ
        not_RB altogether_RB surprising_JJ because_IN Cry_NNP 1_CD Aa_NNP binding_JJ to_TO 
        Manduca_NNP sexta_NN APN_NNP has_VBZ not_RB been_VBN found_VBN
        to_TO be_VB modulated_JJ by_IN sugar_NN binding_JJ [_NN 8_CD ]_NN and_CC the_DT 
        B_NNP ._. mori_NN APN_NNP sequence_NN is_VBZ 73_CD ._. 7_CD %_NN
        identical_JJ to_TO 
        M_NNP ._. sexta_NN APN-_NNP 1_CD ._. Sequence_NNP alignments_NNS
        with_IN 
        Plutella_NNP xylostella_NN APN_NNP receptor_NN
        indicate_VBP that_IN a_DT highly_RB conserved_JJ region_NN of_IN APN_NNP likely_JJ
        functions_NNS as_IN the_DT toxin_NN binding_JJ site_NN [_NN 9_CD ]_NN ._. By_IN testing_NN for_IN
        toxin_NN binding_JJ to_TO lysylendopeptidase-digested_JJ 
        B_NNP ._. mori_NN APN_NNP fragments_NNS ,_, the_DT toxin_NN
        binding_JJ site_NN was_VBD suggested_VBN to_TO be_VB between_IN Ile_NNP 135_CD and_CC Pro_FW 198_CD ._.
        A_DT later_JJ study_NN by_IN these_DT authors_NNS identified_VBD 120_CD -_: kDa_NN and_CC
        115_CD -_: kDa_NN APNs_NNP coeluting_VBG from_IN an_DT anion-exchange_JJ column_NN that_IN
        together_RB yielded_VBD a_DT Cry_NNP 1_CD Aa_NNP affinity_NN of_IN 53_CD nM_NN [_NN 10_CD ]_NN ._. These_DT
        APNs_NNP eluted_JJ just_RB prior_RB to_TO a_DT 120_CD kDa_NN APN_NNP with_IN 7_CD ._. 6_CD nM_NN
        affinity_NN ._. It_PRP is_VBZ unclear_JJ whether_IN the_DT 120_CD -_: and_CC 115_CD -_: kDa_NN
        proteins_NNS represent_VBP uncleaved_JJ and_CC cleaved_JJ GPI-anchor_NNP
        isozymes_NNS ._. Interestingly_RB ,_, this_DT study_NN also_RB showed_VBD that_IN Cry_NNP 1_CD Ac_NNP
        toxin_NN binds_NNS to_TO the_DT 120_CD /_NN 115_CD kDa_NN APN_NNP fraction_NN with_IN equal_JJ
        affinity_NN as_IN Cry_NNP 1_CD Aa_NNP ,_, and_CC only_RB 4_CD -_: fold_VB reduced_VBN affinity_NN to_TO the_DT
        isolated_VBN 120_CD -_: kDa_NN APN_NNP ._. Nonetheless_RB ,_, Cry_NNP 1_CD Aa_NNP is_VBZ 210_CD times_NNS more_RBR
        toxic_JJ than_IN Cry_NNP 1_CD Ac_NNP to_TO 
        B_NNP ._. mori_NN [_NN 4_CD ]_NN ._. As_IN a_DT whole_NN ,_, 
        B_NNP ._. mori_NN APN_NNP research_NN indicates_VBZ the_DT
        presence_NN of_IN at_IN least_JJS three_CD genetic_JJ isoforms_NNS [_NN 7_CD 11_CD 12_CD ]_NN ,_,
        with_IN toxin_NN affinities_NNS ranging_VBG from_IN nanomolar_NN to_TO none_NN at_IN
        all_DT ._.
        In_IN addition_NN to_TO APN_NNP ,_, a_DT completely_RB different_JJ toxin_NN
        receptor_NN class_NN has_VBZ been_VBN affinity_NN precipitated_VBD by_IN toxin_NN from_IN
        solubilized_JJ 
        B_NNP ._. mori_NN midgut_NN proteins_NNS ._. In_IN this_DT
        manner_NN ,_, Nagamatsu_NNP 
        et_CC al_NN ._. [_NN 13_CD ]_NN purified_JJ a_DT 175_CD -_: kDa_NN
        glycoprotein_NN (_( BtR_NNP 175_CD )_) that_WDT bound_VBN Cry_NNP 1_CD Aa_NNP toxin_NN ._.
        Interestingly_RB ,_, these_DT authors_NNS did_VBD not_RB observe_VB binding_JJ of_IN
        Cry_NNP 1_CD Aa_NNP to_TO APN-sized_NNP bands_NNS in_IN ligand_NN blot_NN studies_NNS with_IN BBMV_NNP ._.
        Antibodies_NNP produced_VBD to_TO BtR_NNP 175_CD blocked_VBN toxin_NN binding_VBG to_TO the_DT
        receptor_NN in_IN BBMV_NNP ._. The_DT antibody_NN serum_NN also_RB reduced_VBD Cry_NNP 1_CD Aa_NNP
        activity_NN against_IN 
        B_NNP ._. mori_NN when_WRB it_PRP was_VBD fed_VBN to_TO larvae_NN
        prior_RB to_TO toxin_NN addition_NN to_TO the_DT diet_NN [_NN 14_CD ]_NN ._. The_DT same_JJ group_NN
        cloned_VBN and_CC introduced_VBD the_DT BtR_NNP 175_CD gene_NN with_IN a_DT baculovirus_JJ
        vector_NN into_IN 
        Spodptera_NNP frugiperda_NN Sf_NNP 9_CD cells_NNS ._.
        Addition_NNP of_IN Cry_NNP 1_CD Aa_NNP caused_VBD swelling_VBG and_CC lysis_NNS of_IN only_RB the_DT
        Sf_NNP 9_CD cells_NNS expressing_VBG BtR_NNP 175_CD ._. Based_VBN on_IN sequence_NN analysis_NN ,_,
        the_DT receptor_NN was_VBD characterized_VBN as_IN a_DT cadherin-like_JJ
        glycoprotein_NN containing_VBG nine_CD cadherin_NN repeats_VBZ ,_, a_DT membrane_NN
        proximal_NN region_NN ,_, one_CD transmembrane_NN region_NN ,_, and_CC a_DT small_JJ
        cytoplasmic_JJ domain_NN [_NN 15_CD ]_NN ._. Ihara_NNP 
        et_CC al_NN ._. [_NN 16_CD ]_NN also_RB purified_JJ and_CC
        partially_RB sequenced_JJ what_WP was_VBD presumed_VBN to_TO be_VB the_DT same_JJ
        cadherin-like_JJ receptor_NN ._. Binding_NNP studies_NNS indicated_VBD that_IN the_DT
        affinity_NN of_IN the_DT cadherin_NN for_IN Cry_NNP 1_CD Aa_NNP is_VBZ equivalent_JJ to_TO that_DT
        of_IN the_DT brush_NN border_NN membrane_NN vesicles_NNS from_IN 
        B_NNP ._. mori_NN [_NN 16_CD ]_NN ,_, an_DT affinity_NN that_WDT is_VBZ
        substantially_RB lower_JJR than_IN the_DT APN_NNP affinities_NNS reported_VBD ._.
        Recently_RB ,_, cDNA_NN variants_NNS of_IN BtR_NNP 175_CD have_VBP been_VBN discovered_VBN ,_,
        showing_VBG at_IN least_JJS three_CD alleles_NNS of_IN the_DT cadherin-like_JJ
        receptor_NN are_VBP found_VBN in_IN 
        B_NNP ._. mori_NN [_NN 17_CD ]_NN ._. It_PRP is_VBZ likely_JJ that_DT
        glycosylation_NN plays_VBZ a_DT major_JJ role_NN in_IN cadherin-like_JJ receptor_NN
        isoforms_NNS as_IN well_RB ,_, as_IN glycosylation_NN has_VBZ been_VBN observed_VBN
        previously_RB for_IN the_DT 
        M_NNP ._. sexta_NN cadherin-like_JJ receptor_NN BT-R_NNP 
        1_CD [_NN 18_CD ]_NN ._.
        Progress_NNP in_IN research_NN on_IN silkworm_NN receptors_NNS for_IN Bt_NNP toxins_NNS
        has_VBZ provided_VBN a_DT means_NN for_IN assaying_VBG mutant_JJ toxins_NNS with_IN
        potentially_RB altered_VBN binding_JJ and_CC activity_NN ._. In_IN this_DT study_NN ,_, we_PRP
        tested_VBD the_DT hypothesis_NNS that_IN Cry_NNP 1_CD Aa_NNP binds_NNS to_TO both_DT the_DT 120_CD -_: kDa_NN
        
        B_NNP ._. mori_NN APN_NNP and_CC the_DT 175_CD -_: kDa_NN 
        B_NNP ._. mori_NN cadherin-like_JJ protein_NN ._. Based_VBN
        on_IN the_DT previous_JJ work_NN of_IN Ge_NNP ,_, et_CC al_NN ._. [_NN 3_CD ]_NN and_CC Lee_NNP ,_, et_CC al_NN ._. [_NN
        4_CD ]_NN ,_, we_PRP also_RB postulated_JJ that_DT domain_NN II_NNP of_IN Cry_NNP 1_CD Aa_NNP is_VBZ the_DT
        significant_JJ binding_JJ domain_NN ._. These_DT hypotheses_NNS were_VBD tested_VBN
        for_IN the_DT first_JJ time_NN in_IN studies_NNS with_IN purified_JJ ,_, native_JJ 
        B_NNP ._. mori_NN receptors_NNS (_( rather_RB than_IN BBMV_NNP )_)
        under_IN real-time_JJ ,_, non-labeled_JJ toxin_NN binding_JJ conditions_NNS ._.
      
      
        Results_NNS
        
          Bombyx_NNP mori_NN aminopeptidase_NN N_NNP and_CC cadherin-like_JJ
          receptor_NN purification_NN
          To_TO investigate_VB the_DT specificity_NN of_IN Cry_NNP toxins_NNS for_IN 
          B_NNP ._. mori_NN receptors_NNS ,_, the_DT two_CD known_VBN 
          B_NNP ._. mori_NN midgut_NN receptors_NNS were_VBD
          purified_JJ from_IN 
          B_NNP ._. mori_NN BBMV_NNP ._. Solubilized_NNP 
          B_NNP ._. mori_NN BBMV_NNP proteins_NNS were_VBD
          separated_VBN by_IN Q_NNP Sepharose_NNP anion-exchange_JJ chromatography_NN
          and_CC all_DT eluted_JJ fractions_NNS were_VBD tested_VBN for_IN APN_NNP enzymatic_JJ
          activity_NN ._. Additionally_RB ,_, Cry_NNP 1_CD Aa_NNP toxin_NN binding_JJ capability_NN
          was_VBD assayed_JJ by_IN "_'' slot_NN blotting_VBG "_'' all_DT fractions_NNS and_CC probing_VBG
          with_IN biotin-_NN Cry_NNP 1_CD Aa_NNP ._. The_DT chromatogram_NN in_IN Fig_NNP ._. 1_LS displays_NNS
          the_DT separation_NN of_IN cadherin_NN and_CC APN_NNP from_IN BBMV_NNP proteins_NNS ._.
          APN_NNP isozymes_NNS of_IN 100_CD -_: and_CC 110_CD -_: kDa_NN were_VBD detected_VBN that_WDT did_VBD
          not_RB show_VB Cry_NNP 1_CD Aa-binding_NNP in_IN slot_NN blot_NN assays_NNS (_( Fig_NNP ._. 1_LS ;_:
          fractions_NNS 24_CD -_: 25_CD and_CC 30_CD -_: 31_CD )_) ._. Such_JJ isozymes_NNS have_VBP been_VBN
          reported_VBN previously_RB [_NN 11_CD 12_CD ]_NN ._. In_IN addition_NN ,_, a_DT 115_CD -_: kDa_NN
          APN_NNP was_VBD detected_VBN with_IN Cry_NNP 1_CD Aa-binding_NNP capability_NN (_( Fig_NNP ._. 1_LS ;_:
          fractions_NNS 33_CD -_: 36_CD )_) ._. As_IN expected_VBN ,_, fractions_NNS were_VBD also_RB
          observed_VBN that_WDT exhibited_VBN no_DT APN_NNP enzymatic_JJ activity_NN but_CC
          bound_VBN Cry_NNP 1_CD Aa_NNP on_IN slot_NN blots_NNS (_( Fig_NNP ._. 1_LS ;_: fractions_NNS 26_CD -_: 27_CD )_) ._.
          Initially_RB these_DT fractions_NNS were_VBD predicted_VBN to_TO contain_VB the_DT
          cadherin-like_JJ Cry_NNP 1_CD Aa-binding_NNP protein_NN [_NN 13_CD 14_CD 16_CD ]_NN ._. The_DT
          candidate_NN receptor_NN fractions_NNS for_IN APN_NNP and_CC cadherin_NN were_VBD
          separately_RB loaded_VBN on_IN a_DT size-exclusion_JJ column_NN for_IN further_JJ
          purification_NN (_( Fig_NNP ._. 2_LS Aand_NNP 2_CD B_NNP )_) ._. A_DT protein_NN with_IN APN_NNP
          enzymatic_JJ activity_NN eluted_JJ 75_CD minutes_NNS after_IN injection_NN
          (_( Fig_NNP ._. 2_LS A_DT ;_: fractions_NNS 15_CD -_: 16_CD )_) ,_, approximately_RB 4_CD minutes_NNS after_IN
          the_DT 120_CD -_: kDa_NN 
          L_NNP ._. dispar_NN APN_NNP elutes_NNS on_IN the_DT same_JJ
          column_NN [_NN 19_CD ]_NN ._. The_DT candidate_NN cadherin-like_JJ receptor_NN
          fraction_NN eluted_JJ in_IN fractions_NNS 9_CD -_: 11_CD at_IN around_IN 180_CD kDa_NN (_( Fig_NNP ._.
          2_LS B_NNP )_) ._.
        
        
          Analysis_NNP of_IN receptor_NN purity_NN
          The_DT pooled_VBN and_CC concentrated_VBN candidate_NN receptor_NN
          fractions_NNS were_VBD examined_VBN by_IN SDS-PAGE_NNP before_IN and_CC after_IN
          size-exclusion_JJ purification_NN to_TO assess_VB purity_NN (_( Fig_NNP ._. 3_LS )_) ._.
          The_DT putative_JJ cadherin-like_JJ receptor_NN material_NN appears_VBZ at_IN a_DT
          molecular_JJ size_NN around_IN 180_CD kDa_NN ,_, both_DT before_IN and_CC after_IN
          secondary_JJ purification_NN (_( Lanes_NNP 2_CD and_CC 1_CD ,_, respectively_RB )_) ._.
          Several_JJ BBMV_NNP proteins_NNS appear_VBP present_JJ in_IN the_DT
          APN-containing_NNP fraction_NN prior_RB to_TO size-exclusion_JJ
          purification_NN (_( Fig_NNP ._. 3_LS ;_: Lane_NNP 4_LS )_) ._. The_DT molecular_JJ weight_NN of_IN
          the_DT final_JJ ,_, purified_JJ APN_NNP was_VBD estimated_VBN to_TO be_VB 115_CD -_: 120_CD kDa_NN
          (_( Fig_NNP ._. 3_LS ;_: Lane_NNP 3_LS )_) ._. It_PRP is_VBZ not_RB known_VBN whether_IN the_DT GPI_NNP anchor_NN
          is_VBZ still_RB intact_JJ on_IN the_DT APN_NNP receptor_NN ;_: however_RB ,_, in_IN the_DT
          current_JJ study_NN ,_, phosphatidylinositol-specific_JJ
          phospholipase_NN C_NNP (_( PIPLC_NNP )_) was_VBD not_RB used_VBN during_IN BBMV_NNP
          preparation_NN ._. It_PRP was_VBD shown_VBN previously_RB that_IN APN_NNP may_MD be_VB
          purified_JJ with_IN intact_JJ GPI-anchors_NNP if_IN PIPLC_NNP is_VBZ omitted_VBN from_IN
          the_DT preparation_NN buffer_NN [_NN 6_CD ]_NN ._. It_PRP is_VBZ likely_JJ that_IN our_PRP$ APN_NNP
          has_VBZ similarly_RB retained_VBN the_DT GPI_NNP anchor_NN ._.
          In_IN view_NN of_IN the_DT fact_NN that_IN 
          B_NNP ._. mori_NN BtR_NNP 175_CD possesses_VBZ sequence_NN
          similarity_NN to_TO 
          M_NNP ._. sexta_NN BT-R_NNP 
          1_CD ,_, the_DT candidate_NN fraction_NN was_VBD probed_JJ
          on_IN a_DT slot_NN blot_NN with_IN anti-_NN BT-R_NNP 
          1_CD polyclonal_NN antiserum_NN ._. A_DT weak_JJ to_TO
          moderate_VB cross-reactivity_JJ with_IN anti-_NN BT-R_NNP 
          1_CD was_VBD observed_VBN for_IN 
          B_NNP ._. mori_NN BBMV_NNP as_RB well_RB as_IN the_DT
          putative_JJ cadherin-like_JJ receptor_NN fraction_NN ,_, providing_VBG
          strong_JJ evidence_NN that_IN the_DT material_NN is_VBZ a_DT cadherin-like_JJ
          protein_NN (_( Fig_NNP ._. 4_LS )_) ._. Anti-_NNP Bt-_NNP R_NNP 
          1_CD antibody_NN recognition_NN was_VBD not_RB
          observed_VBN for_IN fractions_NNS eluting_VBG before_IN and_CC after_IN the_DT
          cadherin_NN material_NN ,_, nor_CC for_IN the_DT purified_JJ APN_NNP (_( Fig_NNP ._. 4_LS )_) ._.
          Similar_JJ antibody_NN assays_NNS were_VBD not_RB performed_VBN to_TO
          substantiate_VB the_DT identity_NN of_IN the_DT purified_JJ APN_NNP because_IN it_PRP
          clearly_RB displayed_VBD strong_JJ ,_, characteristic_JJ APN_NNP enzyme_NN
          activity_NN ._.
          The_DT purity_NN of_IN both_DT receptors_NNS was_VBD further_RBR examined_VBN by_IN a_DT
          Cry_NNP 1_CD Aa_NNP toxin_NN ligand_NN blot_NN (_( Fig_NNP ._. 5_LS )_) ._. Both_DT APN_NNP and_CC the_DT
          cadherin-like_JJ receptor_NN fractions_NNS bound_VBN biotinylated_JJ
          Cry_NNP 1_CD Aa_NNP ._. No_DT other_JJ toxin-binding_JJ bands_NNS were_VBD apparent_JJ ,_, and_CC
          neither_DT purified_JJ receptor_NN sample_NN was_VBD visibly_RB
          cross-contaminated_JJ with_IN the_DT other_JJ receptor_NN (_( Fig_NNP ._. 5_LS )_) ._.
        
        
          Affinity_NNP estimation_NN by_IN surface_NN plasmon_NN
          resonance_NN
          Cry_NNP toxin_NN binding_JJ studies_NNS have_VBP been_VBN reported_VBN
          previously_RB for_IN 
          B_NNP ._. mori_NN that_WDT used_VBD BBMV_NNP assays_NNS or_CC
          used_VBN purified_JJ receptors_NNS in_IN ELISA_NNP assays_NNS or_CC blots_NNS ;_:
          however_RB ,_, no_DT Cry_NNP toxin_NN studies_NNS concerning_VBG 
          B_NNP ._. mori_NN have_VBP been_VBN published_VBN
          employing_VBG SPR_NNP analysis_NN ._. The_DT affinity_NN of_IN Cry_NNP 1_CD Aa_NNP binding_JJ to_TO
          
          B_NNP ._. mori_NN APN_NNP and_CC 
          B_NNP ._. mori_NN cadherin_NN receptors_NNS was_VBD
          evaluated_VBN by_IN real-time_JJ kinetic_JJ analysis_NN on_IN a_DT BIAcore_NNP
          2000_CD ._. Simple_NN bimolecular_NN binding_JJ of_IN Cry_NNP 1_CD Aa_NNP was_VBD observed_VBN
          to_TO both_DT 
          B_NNP ._. mori_NN APN_NNP and_CC cadherin_NN (_( Fig_NNP ._.
          6_CD Aand_NNP 6_CD B_NNP )_) ._. Toxin-receptor_NNP on-rates_JJ for_IN association_NN (_( 
          k_NN 
          a_DT )_) ,_, off-rates_JJ for_IN dissociation_NN (_( 
          k_NN 
          d_SYM )_) ,_, and_CC overall_JJ binding_JJ affinity_NN (_( 
          k_NN 
          d_SYM /_NN 
          k_NN 
          a_DT ,_, or_CC 
          K_NNP 
          D_NNP )_) were_VBD calculated_VBN for_IN toxin_NN binding_JJ ._.
          The_DT apparent_JJ rate_NN constants_NNS for_IN wild-type_JJ Cry_NNP 1_CD Aa_NNP and_CC 
          B_NNP ._. mori_NN APN_NNP were_VBD 
          k_NN 
          a_DT =_SYM 2_CD ._. 0_CD ×_NN 10_CD 4_CD M_NNP -_: 1_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 1_CD ._. 3_CD ×_NN 10_CD
          2_LS )_) ,_, 
          k_NN 
          d_SYM =_SYM 1_CD ._. 5_CD ×_NN 10_CD -_: 3_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 1_CD ×_NN 10_CD -_: 5_LS )_) ,_,
          and_CC 
          K_NNP 
          D_NNP =_SYM 75_CD nM_NN ._. To_TO 
          B_NNP ._. mori_NN cadherin_NN ,_, significantly_RB
          tighter_JJR affinities_NNS were_VBD obtained_VBN :_: 
          k_NN 
          a_DT =_SYM 1_CD ._. 3_CD ×_NN 10_CD 4_CD M_NNP -_: 1_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 6_CD ._. 1_LS )_) ,_, 
          k_NN 
          d_SYM =_SYM 3_CD ._. 3_CD ×_NN 10_CD -_: 5_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 1_CD ×_NN 10_CD -_: 5_LS )_) ,_, 
          K_NNP 
          D_NNP =_SYM 2_CD ._. 6_CD nM_NN ._. This_DT apparent_JJ off-rate_JJ
          clearly_RB accounted_VBD for_IN Cry_NNP 1_CD Aa_NNP 's_POS higher_JJR affinity_NN for_IN
          cadherin_NN than_IN for_IN APN_NNP ._. The_DT cadherin_NN off-rate_JJ observed_VBD in_IN
          this_DT study_NN could_MD have_VB significant_JJ consequences_NNS in_IN vivo_NN :_:
          slow_JJ toxin_NN dissociation_NN may_MD enable_VB protracted_JJ lingering_VBG
          near_IN the_DT brush_NN border_NN membrane_NN surface_NN ,_, greatly_RB
          facilitating_VBG toxic_JJ (_( domain_NN I_PRP )_) insertion_NN and_CC subsequent_JJ
          pore_NN formation_NN ._. The_DT overall_JJ affinity_NN determined_VBN in_IN the_DT
          present_JJ study_NN for_IN Cry_NNP 1_CD Aa_NNP to_TO BtR_NNP 175_CD (_( 2_CD ._. 6_CD nM_NN )_) agrees_VBZ well_RB
          with_IN the_DT findings_NNS of_IN Ihara_NNP 
          et_CC al_NN ._. [_NN 16_CD ]_NN by_IN a_DT different_JJ assay_NN
          (_( 0_CD ._. 8_CD nM_NN )_) ._.
          We_PRP also_RB explored_JJ the_DT specificity_NN of_IN Cry_NNP 1_CD Aa_NNP for_IN the_DT
          native_JJ 
          B_NNP ._. mori_NN receptors_NNS by_IN comparing_VBG the_DT
          binding_JJ response_NN of_IN Cry_NNP 1_CD Aa_NNP with_IN the_DT binding_JJ of_IN Cry_NNP 1_CD Ab_NNP ,_,
          Cry_NNP 1_CD Ac_NNP ,_, and_CC domain-switched_JJ toxin_NN 4109_CD (_( Fig_NNP ._. 7_CD Aand_NNP 7_CD B_NNP )_) ._.
          Hybrid_NNP toxin_NN 4109_CD is_VBZ particular_JJ useful_JJ in_IN this_DT context_NN ,_,
          because_IN it_PRP is_VBZ comprised_VBN of_IN domains_NNS I_PRP and_CC II_NNP from_IN Cry_NNP 1_CD Aa_NNP
          and_CC domain_NN III_NNP from_IN Cry_NNP 1_CD Ac_NNP (_( Aa_NNP /_NN Aa_NNP /_NN Ac_NNP )_) [_NN 3_CD ]_NN ._.
          Hybrid-toxin_NNP 4109_CD binding_VBG to_TO both_DT receptors_NNS was_VBD not_RB
          noticeably_RB different_JJ from_IN Cry_NNP 1_CD Aa_NNP :_: for_IN APN_NNP binding_JJ ,_, 
          k_NN 
          a_DT =_SYM 1_CD ._. 9_CD ×_NN 10_CD 4_CD M_NNP -_: 1_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 1_CD ._. 4_CD ×_NN 10_CD
          2_LS )_) ,_, 
          k_NN 
          d_SYM =_SYM 1_CD ._. 5_CD ×_NN 10_CD -_: 3_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 1_CD ._. 6_CD ×_NN 10_CD -_: 5_LS )_) ,_,
          and_CC 
          K_NNP 
          D_NNP =_SYM 78_CD nM_NN ;_: for_IN cadherin_NN binding_JJ ,_, 
          k_NN 
          a_DT =_SYM 1_CD ._. 3_CD ×_NN 10_CD 4_CD M_NNP -_: 1_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 2_CD ×_NN 10_CD 2_LS )_) ,_, 
          k_NN 
          d_SYM =_SYM 3_CD ._. 34_CD ×_NN 10_CD -_: 5_CD s_VBZ -_: 1_CD (_( +_NN /_NN -_: 2_CD ×_NN 10_CD -_: 5_LS )_) ,_,
          and_CC 
          K_NNP 
          D_NNP =_SYM 2_CD ._. 6_CD nM_NN ._. In_IN stark_JJ contrast_NN ,_, Cry_NNP 1_CD Ab_NNP
          and_CC Cry_NNP 1_CD Ac_NNP showed_VBD no_DT apparent_JJ binding_JJ to_TO either_CC receptor_NN
          (_( Fig_NNP ._. 7_CD Aand_NNP 7_CD B_NNP )_) ._. These_DT results_NNS are_VBP entirely_RB consistent_JJ
          with_IN the_DT hypothesis_NNS that_IN Cry_NNP 1_CD Aa_NNP domain_NN II_NNP (_( alone_RB )_) is_VBZ
          essential_JJ for_IN binding_VBG to_TO both_DT the_DT APN_NNP and_CC cadherin-like_JJ
          receptors_NNS as_IN purified_JJ in_IN the_DT present_JJ study_NN ._.
        
      
      
        Discussion_NNP
        The_DT dissociation_NN constants_NNS presented_VBN are_VBP the_DT first_JJ
        determined_VBN for_IN 
        B_NNP ._. mori_NN Cry_NNP receptors_NNS by_IN the_DT use_NN of_IN
        SPR_NNP technology_NN ._. Additionally_RB ,_, the_DT apparent_JJ affinity_NN of_IN
        Cry_NNP 1_CD Aa_NNP for_IN the_DT cadherin-like_JJ receptor_NN is_VBZ the_DT highest_JJS
        observed_VBN affinity_NN to_TO date_NN for_IN Cry_NNP toxin_NN binding_JJ to_TO purified_JJ
        receptors_NNS using_VBG SPR_NNP ._. This_DT finding_VBG emphasizes_VBZ the_DT important_JJ
        biological_JJ role_NN that_IN this_DT receptor_NN class_NN plays_VBZ for_IN Bt_NNP
        toxins_NNS ._. Recently_RB ,_, using_VBG phage_NN display_NN technology_NN ,_, a_DT scFv_NN
        molecule_NN with_IN short_JJ sequence_NN homology_NN to_TO 
        M_NNP ._. sexta_NN and_CC 
        B_NNP ._. mori_NN cadherin-like_JJ receptors_NNS was_VBD
        shown_VBN to_TO bind_NN domain_NN II_NNP of_IN Cry_NNP 1_CD Aa_NNP ,_, Cry_NNP 1_CD Ab_NNP ,_, and_CC Cry_NNP 1_CD Ac_NNP
        toxins_NNS [_NN 20_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, only_RB Cry_NNP 1_CD Aa_NNP shows_VBZ
        measurable_JJ binding_VBG to_TO the_DT purified_JJ ,_, native_JJ cadherin-like_JJ
        receptor_NN from_IN 
        B_NNP ._. mori_NN ._. This_DT finding_VBG may_MD be_VB the_DT
        result_NN of_IN purification_NN of_IN a_DT particular_JJ receptor_NN variant_NN
        with_IN Cry_NNP 1_CD Aa_NNP specificity_NN (_( e_SYM ._. g_SYM ._. ,_, one_CD of_IN potentially_RB several_JJ
        glycosylated_JJ isoforms_NNS )_) ._. Alternatively_RB ,_, it_PRP may_MD reflect_VB
        greater_JJR specificity_NN of_IN Cry_NNP 1_CD Aa_NNP domain_NN II_NNP for_IN neighboring_VBG
        residues_NNS on_IN the_DT 
        B_NNP ._. mori_NN cadherin-like_JJ receptor_NN beyond_IN
        the_DT conserved_JJ Cry_NNP 1_CD A-_NNP toxin_NN binding_JJ segment_NN ,_, which_WDT might_MD be_VB
        absent_JJ in_IN smaller_JJR peptide_NN sequences_NNS ._.
        The_DT apparent_JJ Cry_NNP 1_CD Aa_NNP affinity_NN for_IN purified_JJ APN_NNP measured_VBD
        in_IN this_DT study_NN ,_, 75_CD nM_NN ,_, is_VBZ 10_CD -_: fold_VB higher_JJR than_IN the_DT value_NN
        reported_VBN by_IN Yaoi_NNP 
        et_CC al_NN ._. [_NN 6_CD ]_NN for_IN purified_JJ 110_CD -_: kDa_NN APN_NNP
        using_VBG a_DT separate_JJ technique_NN (_( 7_CD ._. 6_CD nM_NN )_) ._. In_IN the_DT aforementioned_JJ
        study_NN ,_, an_DT ELISA_NNP assay_NN was_VBD used_VBN to_TO indirectly_RB calculate_VB
        affinity_NN by_IN incubating_VBG receptor-bound_JJ toxin_NN with_IN a_DT
        peroxidase-conjugated_JJ anti-_NN Cry_NNP 1_CD Aa_NNP antibody_NN over_IN 1_CD ._. 5_CD hours_NNS
        at_IN 37_CD °_NN C_NNP ._. It_PRP is_VBZ possible_JJ that_IN the_DT difference_NN in_IN binding_JJ
        constants_NNS reflects_VBZ our_PRP$ condition_NN of_IN more_JJR direct_JJ
        receptor-binding_JJ measurement_NN in_IN "_'' real-time_JJ "_'' ,_, as_RB well_RB as_IN the_DT
        different_JJ binding_JJ buffers_NNS and_CC temperature_NN used_VBN ._.
        Yaoi_NNP 
        et_CC al_NN ._. [_NN 21_CD ]_NN estimated_VBD the_DT
        toxin-binding_JJ region_NN of_IN 
        B_NNP ._. mori_NN APN_NNP to_TO be_VB between_IN Ile_NNP 135_CD and_CC
        Pro_FW 198_CD based_VBN on_IN toxin_NN blot_NN overlays_VBZ with_IN protease-digested_JJ
        APN_NNP fragments_NNS ._. BLAST_NN sequence_NN alignments_NNS [_NN 22_CD ]_NN yielded_VBD 81_CD %_NN
        identity_NN and_CC 96_CD %_NN similarity_NN between_IN this_DT 63_CD residue_NN stretch_NN
        and_CC the_DT homologous_RB region_NN of_IN 
        M_NNP ._. sexta_NN APN-_NNP 1_CD ,_, which_WDT also_RB binds_NNS
        Cry_NNP 1_CD Aa_NNP toxin_NN (_( Jenkins_NNP ,_, unpublished_JJ observation_NN )_) ._.
        Interestingly_RB ,_, in_IN 
        L_NNP ._. dispar_NN APN-_NNP 1_CD ,_, which_WDT does_VBZ not_RB bind_NN
        Cry_NNP 1_CD Aa_NNP ,_, the_DT same_JJ stretch_NN is_VBZ only_RB 37_CD %_NN identical_JJ and_CC 56_CD %_NN
        similar_JJ (_( 4_CD %_NN unaligned_JJ gaps_NNS )_) ._. These_DT results_NNS appear_VBP to_TO
        support_VB the_DT findings_NNS of_IN Yaoi_NNP 
        et_CC al_NN ._. [_NN 21_CD ]_NN ._. However_RB ,_, 
        Heliothis_NNP virescens_NNS (_( tobacco_NN budworm_NN )_)
        APN_NNP is_VBZ only_RB 45_CD %_NN identical_JJ and_CC 53_CD %_NN similar_JJ to_TO 
        B_NNP ._. mori_NN APN_NNP ,_, yet_RB it_PRP binds_NNS Cry_NNP 1_CD Aa_NNP
        toxin_NN with_IN high_JJ affinity_NN [_NN 23_CD ]_NN ._. Moreover_RB ,_, sequence_NN
        alignments_NNS with_IN APN_NNP from_IN 
        Lactobacillus_NNP ,_, 
        Streptococcus_NNP ,_, 
        Saccharomyces_NNP ,_, 
        Arabidopsis_NNP ,_, rat_NN ,_, pig_NN ,_, yeast_NN ,_, and_CC
        human_NN yielded_VBD more_JJR similarity_NN than_IN 
        H_NNP ._. virescens_NNS APN_NNP to_TO the_DT putative_JJ
        Cry_NNP 1_CD Aa-binding_NNP region_NN of_IN 
        B_NNP ._. mori_NN APN_NNP ._. It_PRP is_VBZ likely_JJ that_IN as_IN the_DT
        X-_NNP ray_NN crystal_NN structures_NNS of_IN APNs_NNP are_VBP solved_VBN ,_, structural_JJ
        alignments_NNS of_IN APNs_NNP will_MD help_VB resolve_VB the_DT
        specificity-determining_JJ regions_NNS more_RBR accurately_RB ._.
        Additionally_RB ,_, structural_JJ information_NN will_MD aid_VB in_IN the_DT
        rational_JJ construction_NN of_IN toxins_NNS with_IN reduced_VBN binding_JJ for_IN
        beneficial_JJ insects_NNS without_IN losing_VBG activity_NN to_TO target_VB pests_NNS ._.
        In_IN this_DT context_NN a_DT unique_JJ Cry_NNP 1_CD Aa_NNP binding_JJ epitope_NN within_IN
        domain_NN II_NNP has_VBZ been_VBN identified_VBN that_IN ,_, when_WRB mutated_VBN ,_, results_NNS
        in_IN specific_JJ reduction_NN of_IN toxicity_NN to_TO 
        B_NNP ._. mori_NN (_( You_PRP ,_, et_CC al_NN ._. ,_, unpublished_JJ
        manuscript_NN )_) ._. The_DT application_NN of_IN protein_NN engineering_NN to_TO 
        B_NNP ._. thuringiensis_NNS insecticidal_NN
        proteins_NNS is_VBZ entering_VBG a_DT new_JJ era_NN of_IN tailoring_VBG pesticides_NNS with_IN
        reduced_VBN activity_NN to_TO beneficial_JJ insects_NNS as_RB well_RB as_IN
        increasing_VBG activity_NN against_IN pest_NN insects_NNS [_NN 24_CD ]_NN ._.
      
      
        Conclusions_NNP
        Domain_NNP II_NNP of_IN Cry_NNP 1_CD Aa_NNP is_VBZ both_DT necessary_JJ and_CC essential_JJ for_IN
        tight_JJ binding_JJ to_TO two_CD 
        B_NNP ._. mori_NN midgut_NN receptors_NNS ,_, the_DT
        cadherin-like_JJ and_CC aminopeptidase_NN N_NNP receptors_NNS ,_, a_DT finding_VBG
        that_IN correlates_NNS with_IN biological_JJ activity_NN data_NNS ._. The_DT Cry_NNP 1_CD Aa_NNP
        binding_JJ affinity_NN ,_, as_RB well_RB as_IN the_DT dissociation_NN rate_NN for_IN the_DT
        cadherin-like_JJ receptor_NN ,_, are_VBP the_DT lowest_JJS measured_VBN using_VBG the_DT
        surface_NN plasmon_NN resonance_NN technique_NN ._. The_DT SPR_NNP method_NN
        presented_VBN here_RB may_MD be_VB useful_JJ for_IN screening_NN other_JJ Cry_NNP toxins_NNS
        or_CC Cry_NNP toxin_NN variants_NNS specifically_RB engineered_VBN to_TO reduce_VB or_CC
        eliminate_VB specificity_NN for_IN receptors_NNS from_IN this_DT non-target_JJ
        insect_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Mutant_NNP toxin_NN construction_NN and_CC preliminary_JJ
          analysis_NN
          Hybrid_NNP toxin_NN 4109_CD consisting_VBG of_IN domains_NNS I_PRP and_CC II_NNP of_IN
          Cry_NNP 1_CD Aa_NNP and_CC domain_NN III_NNP of_IN Cry_NNP 1_CD Ac_NNP was_VBD constructed_VBN as_RB
          previously_RB described_VBD [_NN 3_CD ]_NN ._. Force-feeding_NNP bioassays_NNS on_IN 
          B_NNP ._. mori_NN and_CC BBMV_NNP binding_JJ assays_NNS
          were_VBD conducted_VBN as_IN described_VBN [_NN 4_CD ]_NN ._. Crystal_NNP proteins_NNS were_VBD
          solubilized_JJ and_CC trypsinized_JJ ,_, and_CC active_JJ toxins_NNS were_VBD
          column_NN purified_JJ as_IN carried_VBN out_IN previously_RB [_NN 19_CD ]_NN ._.
        
        
          Receptor_NNP purification_NN
          
          B_NNP ._. mori_NN midguts_NNS were_VBD dissected_VBN from_IN
          4_CD thor_NN 5_CD thinstar_NN larvae_NN and_CC brush_NN border_NN membrane_NN
          vesicles_NNS were_VBD prepared_VBN by_IN the_DT Wolfersberger_NNP method_NN [_NN 25_CD ]_NN
          ._. 
          B_NNP ._. mori_NN BBMV_NNP (_( 10_CD mg_NN in_IN 10_CD ml_NN )_) was_VBD
          solubilized_JJ in_IN 5_CD mg_NN /_NN ml_NN CHAPS_NNP zwitterionic_JJ detergent_NN
          (_( Roche_NNP )_) overnight_JJ at_IN 4_CD oC_NN with_IN gentle_JJ rocking_VBG ._.
          Solubilized_NNP BBMV_NNP was_VBD centrifuged_JJ at_IN 10_CD ,_, 000_CD ×_NN g_SYM for_IN 10_CD min_NN
          and_CC supernatant_NN was_VBD concentrated_VBN to_TO 2_CD ml_NN by_IN Amicon_NNP YM_NNP 30_CD
          ultrafiltration_NN ._. The_DT sample_NN was_VBD then_RB loaded_VBN on_IN a_DT Q_NNP
          Sepharose_NNP HR_NNP 10_CD /_NN 30_CD anion-exchange_JJ column_NN ._. All_DT column_NN
          chromatography_NN was_VBD carried_VBN out_IN on_IN an_DT ÄKTA_NN Explorer_NNP
          (_( Amersham_NNP Pharmacia_NNP Biotech_NNP )_) ._. Low_NNP salt_NN buffer_NN (_( buffer_NN A_DT )_)
          consisted_VBD of_IN 20_CD mM_NN Tris_NNP ,_, 5_CD mM_NN MgCl_NNP ,_, 0_CD ._. 4_CD mg_NN /_NN ml_NN CHAPS_NNP ,_, pH_NN
          8_CD ._. 6_CD ,_, and_CC the_DT high_JJ salt_NN buffer_NN used_VBN was_VBD buffer_NN A_DT
          containing_VBG 1_CD M_NNP NaCl_NNP ._. A_DT step_NN gradient_NN of_IN salt_NN was_VBD used_VBN to_TO
          elute_NN BBMV_NNP proteins_NNS ._. All_DT fractions_NNS were_VBD tested_VBN for_IN APN_NNP
          enzymatic_JJ activity_NN by_IN the_DT LpNA_NNP assay_NN ._. Briefly_NNP ,_, 390_CD μl_NN of_IN
          sample_NN are_VBP mixed_VBN with_IN 10_CD μl_NN of_IN 2_CD mM_NN
          leucine-p-nitroanilide_JJ (_( containing_VBG a_DT
          leucine-phenylalanine_JJ dipeptide_NN )_) ._. A_DT yellow_JJ chromophoric_JJ
          change_NN indicates_VBZ aminopeptidase_NN N_NNP activity_NN ,_, defined_VBN as_IN
          the_DT ability_NN to_TO cleave_NN a_DT neutral_JJ amino_JJ acid_NN from_IN the_DT
          N-_NNP terminus_JJ of_IN a_DT polypeptide_NN ._. Cry_NNP 1_CD Aa_NNP binding_JJ ability_NN was_VBD
          also_RB checked_VBN by_IN slot_NN blotting_VBG fractions_NNS to_TO PVDF_NNP membrane_NN
          and_CC probing_VBG with_IN biotinylated_JJ Cry_NNP 1_CD Aa_NNP [_NN 26_CD ]_NN ._. Fractions_NNP
          with_IN Cry_NNP 1_CD Aa-binding_NNP ability_NN and_CC APN_NNP enzymatic_JJ activity_NN
          were_VBD concentrated_VBN to_TO 2_CD ml_NN volumes_NNS and_CC loaded_VBN on_IN a_DT
          Superdex_NNP 200_CD size-exclusion_JJ column_NN (_( 120_CD ml_NN bed_NN volume_NN )_)
          using_VBG Hepes-buffered_NNP saline_NN (_( HBS_NNP ;_: 10_CD mM_NN Hepes_NNP ,_, 150_CD mM_NN
          NaCl_NNP ,_, 3_CD ._. 4_CD mM_NN EDTA_NNP ,_, pH_NN 7_CD ._. 4_LS )_) as_IN running_VBG buffer_NN ._. Absorbance_NNP
          was_VBD monitored_VBN at_IN 280_CD nm_NN and_CC 260_CD nm_NN to_TO judge_VB protein_NN
          purity_NN of_IN collected_VBN peaks_NNS relative_JJ to_TO flow_VB through_IN ._.
          Fractions_NNP eluting_VBG around_IN 115_CD -_: 120_CD kDa_NN ,_, the_DT MW_NNP of_IN APN_NNP ,_, were_VBD
          collected_VBN and_CC protease_NN inhibitors_NNS were_VBD added_VBN after_IN a_DT
          final_JJ concentration_NN ._. Anion-exchange_NNP fractions_NNS with_IN
          Cry_NNP 1_CD Aa-binding_NNP ability_NN but_CC without_IN APN_NNP enzymatic_JJ activity_NN
          were_VBD also_RB size-purifed_JJ ,_, and_CC fractions_NNS eluting_VBG around_IN
          175_CD -_: 250_CD kDa_NN ,_, the_DT MW_NNP of_IN BtR_NNP 175_CD ,_, were_VBD collected_VBN and_CC
          concentrated_VBN ._. Approximately_RB 0_CD ._. 10_CD mg_NN (_( in_IN 0_CD ._. 25_CD ml_NN )_) of_IN
          cadherin-like_JJ receptor_NN and_CC 0_CD ._. 30_CD mg_NN of_IN APN_NNP (_( in_IN 1_CD ml_NN )_) were_VBD
          obtained_VBN ._.
        
        
          Analysis_NNP of_IN receptor_NN purity_NN
          Candidate_NNP receptor_NN fractions_NNS were_VBD analyzed_VBN by_IN 10_CD %_NN
          SDS-PAGE_NNP (_( 40_CD μl_NN /_NN lane_NN )_) and_CC stained_JJ with_IN Coomassie_NNP
          brilliant_JJ blue_NN ._. For_IN slot_NN blot_NN assays_NNS ,_, 5_CD μg_NN of_IN 
          M_NNP ._. sexta_NN or_CC 
          B_NNP ._. mori_NN BBMVs_NNP and_CC 40_CD μl_NN of_IN
          candidate_NN receptor_NN fractions_NNS were_VBD blotted_JJ onto_IN PVDF_NNP
          membrane_NN and_CC assays_NNS was_VBD carried_VBN out_IN as_IN reported_VBN
          previously_RB [_NN 27_CD ]_NN ,_, except_IN for_IN using_VBG 1_CD :_: 1000_CD anti-_NN Bt-_NNP R_NNP 
          1_CD polyclonal_NN antiserum_NN ._. For_IN ligand_NN
          blot_NN assays_NNS ,_, samples_NNS separated_VBN by_IN SDS-PAGE_NNP (_( 9_CD %_NN )_) were_VBD
          transferred_VBN to_TO PVDF_NNP overnight_JJ ,_, blocked_VBN with_IN 5_CD %_NN dried_VBD milk_NN
          in_IN TTBS_NNP (_( 50_CD mM_NN Tris-_NNP HCl_NNP ,_, 150_CD mM_NN NaCl_NNP ,_, 0_CD ._. 05_CD %_NN Tween_NNP 20_CD ,_, pH_NN
          7_CD ._. 5_LS )_) ._. Samples_NNP were_VBD probed_JJ with_IN 50_CD μg_NN biotin-_NN Cry_NNP 1_CD Aa_NNP and_CC
          streptavidin-conjugated_JJ horseradish_NN peroxidase_NN for_IN 1_CD hr_NN
          each_DT ,_, with_IN 45_CD min_NN TTBS_NNP washes_NNS ,_, and_CC developed_VBD in_IN DAB_NNP /_NN Urea_NNP
          (_( BioRad_NNP )_) ._.
        
        
          Surface_NNP plasmon_NN resonance_NN with_IN purified_JJ midgut_NN
          receptors_NNS
          
          B_NNP ._. mori_NN APN_NNP and_CC cadherin_NN were_VBD
          immobilized_JJ on_IN a_DT CM_NNP 5_CD sensor_NN chip_NN by_IN the_DT amine-coupling_JJ
          method_NN (_( Biacore_NNP AB_NNP )_) ._. Receptors_NNP were_VBD diluted_VBN into_IN ammonium_NN
          acetate_NN ,_, pH_NN 4_CD ._. 2_CD prior_RB to_TO immobilization_NN ._. An_DT HBS_NNP (_( pH_NN 7_CD ._. 4_LS )_)
          buffer_NN flow_NN rate_NN of_IN 50_CD μl_NN /_NN min_NN was_VBD used_VBN for_IN all_DT
          injections_NNS ._. Randomized_NNP toxin_NN concentrations_NNS varying_VBG from_IN
          100_CD nM_NN to_TO 1000_CD nM_NN were_VBD injected_VBN (_( 110_CD μl_NN )_) over_IN the_DT
          receptor_NN surfaces_VBZ ._. Surfaces_NNP were_VBD regenerated_JJ with_IN 6_CD μl_NN
          pulses_NNS of_IN 10_CD mM_NN NaOH_NNP ,_, 250_CD μM_NN ethylene_NN glycol_NN ,_, pH_NN 11_CD ._. 0_CD at_IN
          100_CD μl_NN /_NN min_NN ._. Signal_NNP responses_NNS from_IN a_DT blank_JJ flowcell_NN
          containing_VBG ethanolamine_NN as_IN a_DT blocking_VBG agent_NN were_VBD
          subtracted_VBN from_IN all_DT response_NN curves_NNS and_CC data_NNS were_VBD fitted_JJ
          using_VBG BIAevaluation_NNP 3_CD ._. 0_CD ._. The_DT curves_NNS were_VBD fit_VBN to_TO a_DT simple_JJ
          1_CD :_: 1_CD Langmuir_NNP binding_JJ model_NN to_TO obtain_VB apparent_JJ rate_NN
          constants_NNS (_( A_DT +_NN B_NNP ↔_NN AB_NNP )_) ._.
        
      
      
        List_NN of_IN abbreviations_NNS
        Bt_NNP ,_, 
        Bacillus_NN thuringiensis_NNS ;_: APN_NNP ,_,
        aminopeptidase_NN N_NNP ;_: GPI_NNP ,_, glycosyl-phosphatidylinositol_JJ ;_: BBMV_NNP ,_,
        brush_NN border_NN membrane_NN vesicles_NNS ;_: LpNA_NNP ,_,
        leucine-p-nitroanilide_JJ ;_: PIPLC_NNP ,_,
        phosphatidylinositol-specific_JJ phospholipase_NN C_NNP ;_: HBS_NNP ,_,
        Hepes-buffered_NNP saline_NN ;_: SPR_NNP ,_, surface_NN plasmon_NN resonance_NN
      
    
  
